CHICAGO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Valence Health today announced that it has signed a collaboration agreement with Aon plc (NYSE:AON) to jointly assist hospitals and health systems transitioning to value-based care models. This co-marketing relationship combines the reach and expertise of Aon, a leading global provider of risk management, insurance brokerage and reinsurance brokerage, and human resources solutions and outsourcing services, with Valence Health's capabilities and proven 20-year track record as a leading provider of clinical integration, population health, and value-based care solutions and services. As part of this collaboration agreement, the firms will jointly approach and provide solutions to leading hospitals and health systems that are either actively transitioning to a value-based care model or evaluating a transition.
"By combining Valence Health's experience in evaluating, implementing and managing various forms of value-based care with Aon's industry-leading risk and benefits expertise, we can give providers a complete set of resources and capabilities to migrate from today's predominantly fee-for-service delivery system, to tomorrow's fee-for-value system," said R. Andrew Eckert, CEO of Valence Health. "Valence Health and Aon can offer easy access to the tools, services and expertise clients need to be operationally, clinically and financially successful. We are pleased to be able to provide our clients access to Aon's world class reinsurance brokerage services, as well as key risk management services and support for private exchanges."
"Aon supports more than 500 of the leading hospitals and health systems in the United States through our risk and benefits solutions," said Matthew Levin, Executive Vice President and Head of Global Strategy at Aon. "By working with Valence Health, we can offer our clients additional value and support as they undertake this fundamental transformation to a value-based care model that works for all stakeholders including consumers, employers, providers, and payors."
Valence Health and Aon have been working together at joint client sites and expect to expand this collaboration in 2016 as hospitals and health systems look to provide innovative, value-based reimbursement options to employers and other patient populations. Bundled payments, narrow networks, private exchanges, branded insurance products, and partial and fully delegated risk are all models expected to be pursued in greater intensity in 2016 due to increased support by the Centers for Medicare and Medicaid Services and the nation's largest payors and employers.
About Valence Health:
Valence Health provides value-based care solutions for hospitals, health systems and physicians to help them achieve clinical and financial rewards for more effectively managing patient populations. Leveraging 20 years of experience, Valence Health works with clients to design, build and manage customized value-based care models including clinically integrated networks, bundled payments, risk-based contracts, accountable care organizations and provider-sponsored health plans. Providers turn to Valence Health's integrated set of advisory services, population health technology and managed services to make the volume-to-value transition with a single partner in a practical and flexible way. Valence Health's more than 900 employees empower 85,000 physicians and 135 hospitals to advance the health of 20 million patients. For more information, visit www.valencehealth.com.
CONTACT: Kevin Weinstein
Chief Growth Officer
Valence Health
312.273.6623
[email protected]
Bridget Hayman
Associate Director, PR and Social Media
Valence Health
312.273.6616
[email protected]


Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Britain Courts Anthropic Amid US Defense Department Dispute
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Apple Turns 50: From Garage Startup to AI Crossroads
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



